[an error occurred while processing this directive]|[an error occurred while processing this directive]
直肠癌术前短疗程放疗立即手术与长疗程放化疗推迟手术的Meta分析
王太芳, 李萌, 潘宏, 吴春丽
中国医科大学附属第四医院放疗科,沈阳 110032
Short-course preoperative radiotherapy with immediate surgery versus long-course chemoradiotherapy with delayed surgery in treatment of rectal cancer:a meta-analysis
Wang Taifang,Li Meng,Pan Hong,Wu Chunli
Department of Radiation Oncology,Fourth Affiliated Hospital of China Medical University,Shenyang 110032,China
Abstract：Objective At present, short-course radiotherapy (SCRT) with immediate surgery and long-course chemoradiotherapy (LCRT) with delayed surgery are extremely important regimens in the treatment of rectal cancer. In this meta-analysis, the clinical efficacy and safety were statistically compared between two regimes. Methods Literatures related to SCRT and LCRT including randomized controlled studies and clinical studies were searched from Cochrane Library, PubMed, Embase, China National Knowledge Infrastructure (CNKI) and Wanfang database with regard to SCRT with immediate surgery or LCRT with delayed surgery. Meta-analysis was conducted by using RevMan 5.3 software. Results Ten studies were finally selected including 5 randomized controlled trials. Meta-analysis demonstrated that the RO resection rate, T downstaging rate,pathological complete response (pCR) rate in the LCRT group were significantly higher than those in the SCRT group. The incidence rate of adverse events in the LCRT group was higher compared with that in the SCRT group. The sphincter-preservation rate,local recurrence rate,distant metastasis rate,disease-free survival rate,overall survival,late toxicity and postoperative complications did not significantly differ between two groups (all P>0.05). Conclusions Compared with SCRT, LCRT can increase the T downstaging rate, R0 resection rate and pCR rate, whereas elevate the incidence rate of acute adverse events. LCRT exerts no significant effect upon overall postoperative complications.
Wang Taifang,Li Meng,Pan Hong et al. Short-course preoperative radiotherapy with immediate surgery versus long-course chemoradiotherapy with delayed surgery in treatment of rectal cancer:a meta-analysis[J]. Chinese Journal of Radiation Oncology, 2019, 28(8): 588-592.
[1] Vironen J,Juhola M,Kairaluoma M,et al. Tumour regression grading in the evaluation of tumour response after different preoperative radiotherapy treatments for rectal carcinoma[J]. Int J Colorectal Dis,2005,20(5):440-445. DOI:10.1007/s00384-004-0733-y. [2] Bujko K,Nowacki MP,Nasierowska-Guttmejer A,et al. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer[J]. Br J Surg,2006, 93(10):1215-1223. DOI:10.1002/bjs.5506. [3] Bujko K,Michalski W,Kepka L,et al. Association between pathologic response in metastatic lymph nodes after preoperative chemoradiotherapy and risk of distant metastases in rectal cancer:An analysis of outcomes in a randomized trial[J]. Int J Radiat Oncol Biol Phys,2007,67(2):369-377. DOI:10.1016/j.ijrobp.2006.08.065. [4] Pettersson D,Cedermark B,Holm T,et al. Interim analysis of the Stockholm Ⅲ trial of preoperative radiotherapy regimens for rectal cancer[J]. Br J Surg,2010,97(4):580-587. DOI:10.1002/bjs.6914. [5] Pettersson D,Glimelius B,Iversen H,et al. Impaired postoperative leucocyte counts after preoperative radiotherapy for rectal cancer in the Stockholm Ⅲ trial[J]. Br J Surg,2013,100(7):969-975. DOI:10.1002/bjs.9117. [6] Ngan SY,Burmeister B,Fisher RJ,et al. Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer:Trans-Tasman Radiation Oncology Group trial 01.04[J]. J Clin Oncol,2012,30(31):3827-3833. DOI:10.1200/JCO.2012.42.9597. [7] Yeh CH,Chen MF,Lai CH,et al. Comparison of treatment results between surgery alone,preoperative short-course radiotherapy,or long-course concurrent chemoradiotherapy in locally advanced rectal cancer[J]. Int J Clin Oncol,2012,17(5):482-490. DOI:10.1007/s10147-011-0317-0. [8] Ansari N,Solomon MJ,Fisher RJ,et al. Acute adverse events and postoperative complications in a randomized trial of preoperative short-course radiotherapy versus long-course chemoradiotherapy for T3 adenocarcinoma of the rectum:Trans-Tasman Radiation Oncology Group Trial (TROG 01.04)[J]. Ann Surg,2017,265(5):882-888. DOI:10.1097/SLA.0000000000001987. [9] Bosch SL,van Rooijen SJ,Bokkerink GM,et al. Acute toxicity and surgical complications after preoperative (chemo) radiation therapy for rectal cancer in patients with inflammatory bowel disease[J]. Radiother Oncol,2017,123(1):147-153. DOI:10.1016/j.radonc.2017.02.009. [10] Eitta MA,El-Wahidi GF,Fouda MA,et al. Preoperative radiotherapy in resectable rectal cancer:a prospective randomized study of two different approaches[J]. J Egypt Natl Canc Inst,2010,22(3):155-164. [11] Klenova A,Georgiev R,Kurtev P,et al. Short versus conventional preoperative radiotherapy of rectal cancer:indications[J]. J BUON,2007,12(2):227-232. [12] Krajcovicova I,Boljesikova E,Sandorova M,et al. Preoperative radiotherapy of locally advanced rectal cancer:clinical outcome of short-course and long-course treatment with or without concomitant chemotherapy[J]. Klin Onkol,2012,25(5):364-369. [13] Zhou ZR,Liu SX,Zhang TS,et al. Short-course preoperative radiotherapy with immediate surgery versus long-course chemoradiation with delayed surgery in the treatment of rectal cancer:a systematic review and meta-analysis[J]. Surg Oncol,2014,23(4):211-221. DOI:10.1016/j.suronc.2014.10.003. [14] Chen K,Xie G,Zhang Q,et al. Comparison of short-course with long-course preoperative neoadjuvant therapy for rectal cancer:A meta-analysis[J]. J Cancer Res Ther,2018,14 Suppl:S224-S231. DOI:10.4103/0973-1482.202231. [15] Mowery YM,Salama JK,Zafar SY,et al. Neoadjuvant long-course chemoradiation remains strongly favored over short-course radiotherapy by radiation oncologists in the United States[J]. Cancer,2017,123(8:1434-1441. DOI:10.1002/cncr.30461. [16] Hanly P,Ceilleachair AO,Skally M,et al. Direct costs of radiotherapy for rectal cancer:a microcosting study[J]. BMC Heal Serv Res,2015,15:184. DOI:10.1186/s12913-015-0845-9. [17] 刘菊英,陈震章,刘雅恬,等.Ⅱ/Ⅲ期直肠癌术前短程放疗与常规放化疗疗效的Meta分析[J]. 中国肿瘤外科杂志,2014,6(06):367-371. Liu JY,Chen ZZ,Liu YT,et al. Meta-analysis of the efficacy of preoperative short-term radiotherapy and conventional radiotherapy and chemotherapy for stage Ⅱ/Ⅲ rectal cancer[J]. Chin J Oncol Surg,2014,6(6):367-371. [18] Liu SX,Zhou ZR,Chen LX,et al. Short-course versus long-course preoperative radiotherapy plus delayed surgery in the treatment of rectal cancer:a Meta-analysis[J]. As Paci J Cancer Prevent,2015,16(14):5755-5762. [19] 李帅,金晶,叶枫,等. 新辅助治疗评分预测临床Ⅲ期中低位直肠癌预后研究[J]. 中华放射肿瘤学杂志,2018,(5):467-472. DOI:10.3760/cma.j.issn.1004-4221.2018.05.007. Li S,Jin J,Ye F,et al. Prognostic study of neoadjuvant therapy sScore in clinical Stage Ⅲ middle and low rectal cancer[J]. Chin J Radiat Oncol,2018,(5):467-472. DOI:10.3760/cma.j.issn.1004-4221.2018.05.007.
2019, Vol. 28 
